To investigate whether HLA-A, -B, -C, and -DR alloantigen frequencies are different in diabetic patients with and without necrobiosis lipoidica diabeticorum we studied 37 insulin-dependent (Type I) diabetics, 15 with and 22 without necrobiosis, and 96 normal control subjects. Compared to controls Type I diabetics had increased frequencies of B8, CW3, and DR4 and decreased frequencies of DR5 and DR7. Diabetics with necrobiosis differed from diabetics without necrobiosis only in that HLA-A2 was significantly less frequent in patients with necrobiosis. It is suggested that the lack of major differences between patients with and without necrobiosis argues in favour of the role of metabolic and/or vascular rather than genetic factors in the aetiology of necrobiosis.
Introduction
Several lines of evidence indicate that insulindependent diabetes mellitus (Type I) is a heterogeneous disorder (Cahill and McDevitt, 1981; Dornan et al., 1982) . Numerous studies also suggest that susceptibility to the disease is inherited and definite associations have been demonstrated between insulin-dependent diabetes and certain alleles ofthe HLA major histocompatibility complex, notably B8, B15, CW3, DR3, and DR4 (Solow et al., 1979; Farid et al., 1979; Platz et al., 1981) . Some of these associations hold regardless of the age of onset of insulindependent diabetes (Pittman et al., 1982) . However, there is variability in the HLA associations of the disease in different populations (Nakao et al., 1977) and researchers disagree as to whether certain HLA phenotypes predispose diabetics to complications of the disease (Bodansky et al., 1982; Dornan et al, 1982) .
Necrobiosis lipoidica is a chronic skin lesion, long associated with diabetes mellitus (Hildebrand, Montgomery and Rynearson, 1940; Muller and Winkelmann, 1966) . Different studies have shown that 0-3 to 3*0%o of diabetics have necrobiosis and that women are affected four to five times as frequently as men (Melin, 1964) . Clinically, the lesion has a characteristic appearance and histologically there is evidence of focal degeneration of collagen and significant deposits of lipid surrounded by histiocytes, lymphocytes, epithelioid cells and even giant cells (Ullman and Dahl, 1977) . Although microangiopathy (Muller and Winkelmann, 1966) , immune complex vasculitis and increased platelet aggregability (Eldon, Diaz and Naparstek, 1978) have all been proposed as aetiological factors, the issue remains unresolved.
We studied the HLA-A, -B, -C and -DR alloantigens among Type I diabetics with and without necrobiosis lipoidica to determine whether this skin complication has any HLA antigen associations which may distinguish these two groups of diabetics.
Material and methods Patients
Thirty-seven Caucasian ketosis-prone insulin-dependent diabetics (Type I) were studied. The study was planned in a way that the age, sex distribution and age of onset of diabetes for patients with and without necrobiosis was similar. Fifteen patients (13 females and 2 males) had necrobiosis and twenty-two patients (19 females and 3 males) did not have necrobiosis. Ninety-six normal Caucasian subjects living in the same geographical area and including equal numbers of males and females served as controls. The diagnosis of necrobiosis was made clinically in all instances and, in six patients, also confirmed histologically, and was first detected at a mean age of 15-3 + 5-7 years. Among patients with necrobiosis, the mean patient age was 27 4 ± 5 5 years and the mean age of onset of diabetes was 9 7 + 4-5 years. For patients without necrobiosis, the mean patient age was 29 4 ± 5 4 years and the mean age of onset of diabetes 102 ±42 years. Other complications of diabetes affected 10 out of 15 patients with necrobiosis (10 retinopathy, 6 neuropathy, and 4 nephropathy) and 9 out of 22 patients without necrobiosis (9 retinopathy, 2 neuropathy and 4 nephropathy).
Methods
Tissue typing for HLA-A, -B, and -C antigens was carried out using the standard Terasaki microlymphocytotoxicity technique (Mittal et al., 1968) and antisera obtained from U.C.L.A. and N.I.H. and local sources. The alleles tested for included 13 of the A locus, 17 of the B locus, 4 of the C locus and 10 of the DR locus. For DRW typing, B cells were obtained from whole heparinized blood treated with carbonyl iron (50 mg/10 ml) at 37°C for 10 min, then decanted and diluted 10% with Hanks balanced salt solution and layered and centrifuged at 1500 g for 20 min over lymphocyte separating medium (LSM-Litton Bionetics). The monocyte depleted small lymphocytes from the LSM interface were incubated in prewarmed pasteur pipette columns of polymeth-methacrylate beads previously coated with mouse-antimouse Ia antibody cross reactive with human DR (Cedarlane ATH anti ATL). After 30 min incubation, non-adherent cells were washed through the column and adherent B cells were recovered from the beads by agitation, using a modification of the method of Milford et al. (1980) . Sera to detect DRW antigens were obtained from U.C.L.A., N.I.H. and local sources and the microlymphocytotoxicity test was used with I-hr serum and 2-hr complement incubations.
Statistical analysis was performed using Chi square and Fisher's exact test, the former in 2 x 2 comparisons with large numbers and the latter in situations where frequencies of five or less were expected in a given cell (Zar, 1974) .
Results
The 
Discussion
The results of the present comparison of HLA antigen frequencies between insulin-dependent diabetics and controls are in most respects in agreement with other reports. While confirming increased frequencies of B8 (Moerloose et al., 1978) and of B15, CW3 and DR4 (Solow et al., 1979) , we did not find the previously reported increased frequency of DR3 in diabetics (Farid et al., 1979) . The latter may be accounted for by the predominantly female composition of our diabetic sample (Orchard et al., 1982) . On the other hand, we confirmed that there is a significant reduction in the frequency of DR7 (Pittman et al., 1982) and noted a complete absence of DR5 in our diabetic population. Other workers (Solow et al., 1979; Farid et al., 1979) have not found a significantly reduced frequency of DR5 among Type I diabetics but a similar finding has been reported among identical twins with insulin-dependent diabetes (Johnston et al., 1983) .
The insulin-dependent diabetics with necrobiosis included in this study were predominantly female, had classical skin lesions and in 12 of 15 cases the diagnosis of diabetes was made prior to or at the same age as the diagnosis of necrobiosis. They were matched for age, sex and duration of diabetes with patients who did not have necrobiosis. In the comparison of HLA antigens between insulin-dependent diabetics with and without necrobiosis lipoidica, only HLA-A2 had a significantly different frequency in the two groups. Considering the large number of HLA antigens tested, this single difference is unlikely to indicate that these two groups with diabetes are distinct. The lack of major differences between the two groups may also account for the similar preva- Some skin disorders other than necrobiosis also have HLA associations. Generalized granuloma annulare, a skin disease sometimes observed among diabetics, has been associated with a high frequency of BW35 (Friedman-Birnbaum et al., 1978) and psoriasis vulgaris has been associated with B17, CW6 and DR7 (Marcusson, Johanesson and Moller, 1981) . In both instances the HLA antigen associations are different from the negative association with HLA-A2 observed in necrobiosis lipoidica diabeticorum.
Eighty percent of patients with necrobiosis lipoidica have or will develop diabetes mellitus (Muller and Winklemann, 1966) . However, necrobiosis is rare and hence the lack of previous studies addressing the HLA antigen associations of this condition. Even the present results must be interpreted with caution because of the small number of patients studied. Although we found that diabetic patients with necrobiosis have a decreased frequency of HLA-A2 compared to patients without necrobiosis, our findings do not provide convincing evidence that the tendency to develop necrobiosis is genetically determined. Therefore, it seems likely that metabolic and/or vascular factors are more important than genetic factors in the aetiology of necrobiosis diabeticorum.
